1.5-5 Years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 27 (1), 24-33
- https://doi.org/10.1016/0090-8258(87)90227-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985
- Cisplatin nephrotoxicityAmerican Journal of Clinical Oncology, 1985
- Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervixGynecologic Oncology, 1984
- Cyclophosphamide, adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinomaGynecologic Oncology, 1983
- Is there cumulative or delayed toxicity from Cis-platinum?Cancer, 1983
- Influence of Combination Chemotherapy with cis-Diamminedichloroplatinum on Renal Function: Long-Term EffectsOncology, 1983
- Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinomaCancer, 1981
- Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patientsJournal of Surgical Oncology, 1981
- Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in manCancer, 1978
- Improvement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal modelCancer, 1977